3O5Z
Crystal structure of the SH3 domain from p85beta subunit of phosphoinositide 3-kinase (PI3K)
Summary for 3O5Z
| Entry DOI | 10.2210/pdb3o5z/pdb |
| Descriptor | Phosphatidylinositol 3-kinase regulatory subunit beta, CHLORIDE ION, (4S)-2-METHYL-2,4-PENTANEDIOL, ... (4 entities in total) |
| Functional Keywords | src homology 3 domain, protein binding |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 2 |
| Total formula weight | 19811.33 |
| Authors | Chen, S.,Xiao, Y.,Ponnusamy, R.,Tan, J.,Lei, J.,Hilgenfeld, R. (deposition date: 2010-07-28, release date: 2011-08-10, Last modification date: 2024-10-30) |
| Primary citation | Chen, S.,Xiao, Y.,Ponnusamy, R.,Tan, J.,Lei, J.,Hilgenfeld, R. X-ray structure of the SH3 domain of the phosphoinositide 3-kinase p85 beta subunit Acta Crystallogr.,Sect.F, 67:1328-1333, 2011 Cited by PubMed Abstract: Src-homology 3 (SH3) domains are involved in extensive protein-protein interactions and constitute key elements of intracellular signal transduction. Three-dimensional structures have been reported for SH3 domains of various proteins, including the 85 kDa regulatory subunit (p85) of phosphoinositide 3-kinase. However, all of the latter structures are of p85 isoform α and no crystal structure of the SH3 domain of the equally important isoform β has been reported to date. In this structural communication, the recombinant production, crystallization and X-ray structure determination at 2.0 Å resolution of the SH3 domain of human p85β is described. The structure reveals a compact β-barrel fold very similar to that of p85α. However, binding studies with two classes of proline-rich ligand peptides demonstrate that the ligand-binding specificity differs slightly between the SH3 domains of human p85β and p85α, despite their high structural similarity. PubMed: 22102226DOI: 10.1107/S1744309111031691 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.01 Å) |
Structure validation
Download full validation report






